Published in J Natl Cancer Inst on February 05, 2013
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol (2015) 2.02
Screening mammography in older women: a review. JAMA (2014) 1.70
Progress Toward Consensus on Breast Cancer Screening Guidelines and Reducing Screening Harms. JAMA Intern Med (2015) 1.60
Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology (2013) 1.39
Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med (2014) 1.18
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med (2016) 0.94
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med (2016) 0.92
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol (2014) 0.90
To screen or not to screen older women for breast cancer: a conundrum. Future Oncol (2013) 0.85
Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiol (2015) 0.84
Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer. Breast Cancer Res Treat (2014) 0.83
Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83
Performance of digital screening mammography among older women in the United States. Cancer (2014) 0.82
Physician visits and preventive care among Asian American and Pacific Islander long-term survivors of colorectal cancer, USA, 1996-2006. J Cancer Surviv (2013) 0.81
Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses. J Gen Intern Med (2016) 0.79
Evolution of breast cancer screening in the Medicare population: clinical and economic implications. J Natl Cancer Inst (2014) 0.79
Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79
Mammography Screening Among the Elderly: A Research Challenge. Am J Med (2015) 0.78
Breast cancer screening: an evidence-based update. Med Clin North Am (2015) 0.78
Optimal breast cancer screening strategies for older women: current perspectives. Clin Interv Aging (2016) 0.78
Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study. Breast Cancer Res Treat (2016) 0.77
Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. JAMA Oncol (2016) 0.76
Is the false-positive rate in mammography in North America too high? Br J Radiol (2016) 0.76
Surgical margin reporting in breast conserving surgery: Does compliance with guidelines affect re-excision and mastectomy rates? Breast (2015) 0.75
Decision-Making Regarding Mammography Screening for Older Women. J Am Geriatr Soc (2016) 0.75
Evaluation of a Mammography Screening Decision Aid for Women Aged 75 and Older: Protocol for a Cluster-randomized Controlled Trial. J Clin Trials (2015) 0.75
Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening. Cancer J (2017) 0.75
Use of Surveillance Mammography Among Older Breast Cancer Survivors by Life Expectancy. J Clin Oncol (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med (1998) 12.20
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol (2008) 3.49
Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care (2006) 3.08
The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc (2002) 2.42
Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med (1999) 2.38
Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med (2011) 1.98
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71
Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care (2006) 1.70
Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care (2005) 1.55
Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol (1997) 1.52
Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc (2004) 1.48
Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann Intern Med (1992) 1.43
The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc (2002) 1.34
Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer (2011) 1.33
Estimating the cumulative risk of a false-positive test in a repeated screening program. Biometrics (2004) 1.27
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med (2005) 1.25
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat (2011) 1.15
Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol (2009) 0.97
Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst (2006) 0.96
Limiting comorbid conditions and breast cancer stage at diagnosis. J Gerontol A Biol Sci Med Sci (2000) 0.91
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.76
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med (2005) 5.11
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst (2011) 3.62
Mercury levels in high-end consumers of fish. Environ Health Perspect (2003) 3.54
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell (2007) 3.44
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern Med (2015) 3.38
Does this adult patient have septic arthritis? JAMA (2007) 3.28
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res (2002) 3.14
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol (2005) 2.95
The role of trust in use of preventive services among low-income African-American women. Prev Med (2004) 2.90
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst (2007) 2.87
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Is there a useful cesarean birth measure? Assessment of the nulliparous term singleton vertex cesarean birth rate as a tool for obstetric quality improvement. Am J Obstet Gynecol (2006) 2.75
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst (2002) 2.71
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat (2005) 2.53
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov (2012) 2.51
Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain (2005) 2.50
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology (2002) 2.36
Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2007) 2.36
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol (2005) 2.34
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18
Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol (2008) 2.11
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol (2009) 2.10
Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med (2014) 2.08
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07
Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA (2004) 2.07
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control (2014) 2.05
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol (2015) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Mammographic breast density and family history of breast cancer. J Natl Cancer Inst (2003) 1.95
Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res (2004) 1.95
Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev (2003) 1.95
Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med (2005) 1.94
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol (2010) 1.94
Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol (2014) 1.91
Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol (2007) 1.89
Trends in colonoscopy for colorectal cancer screening. Med Care (2007) 1.89
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res (2007) 1.86
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med (2013) 1.84
Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol (2013) 1.82
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81